NIMS hopes to conduct the trials on about 60 candidates but the number would be determined next week once the selection is completed.
The suggestion for change in the study design comes even as most other hospitals chosen for the trial have approved the study protocol, this newspaper has learnt.
None of these vaccines is unlikely to be ready for mass use before 2021 (sic),” an article put out by the ministry said.
The clarification came after its leaked order to 12 hospitals to expedite clinical trials by August 15 sparked widespread criticism.
This development of Covaxin entering human trials has raised hopes of the countrymen in the middle of a massive pandemic.